Bangladesh Drug Administration Director Jailed
This article was originally published in PharmAsia News
The head of Bangladesh's Drug Administration Directorate has been arrested under orders of a court for not testifying in a case brought against BCI Bangladesh over adulterated paracetamol syrup tied to the deaths of 76 children.
You may also be interested in...
The Australian Therapeutic Goods Administration is consulting on a draft standard for data matrix codes on the labels of certain medicines.
Amgen has filed to settle on undisclosed terms patent-infringement litigation involving both its Kanjinti and Mvasi biosimilars, having previously seen originator Genentech fail multiple times to block commercial sales of the products that were launched ‘at risk’.
The WHO’s “Solidarity” trial investigators have decided to interrupt the trials with immediate effect since the clinical trial found that hydroxychloroquine and lopinavir/ritonavir “produced little or no reduction in the mortality of the hospitalized COVID-19 patients.”